Celltrion USA Expands Patient Access to ZYMFENTRA® Through Agreement with Cigna and Express Scripts

Celltrion USA announced that it has signed an agreement with Cigna Healthcare, the health benefits provider of the Cigna Group and Express Scripts, the p...

August 29, 2024 | Thursday | News
Biocon Biologics Secures Global Market Access for Bmab 1200 with Janssen Settlement Agreement

  Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd , announced that the Company has sign...

August 29, 2024 | Thursday | News
Eli Lilly Launches Affordable Zepbound® Single-Dose Vials for Self-Pay Patients, Offering Over 50% Savings on Obesity Treatment

Distributed through LillyDirect®'s self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incr...

August 28, 2024 | Wednesday | News
Sibel Health Expands Capabilities with New FDA Clearances for ANNE® Wearable Sensors

Sibel Health announces two additional FDA-clearances enabling its advanced wearable sensors to operate with compatible third party software applications. I...

August 23, 2024 | Friday | News
FDA Accepts Application for Opdivo Plus Yervoy as First-Line Treatment for Unresectable Hepatocellular Carcinoma

Acceptance based on Phase 3 CheckMate -9DW trial results demonstrating improved survival with Opdivo (nivolumab) plus Yervoy(ipilimumab) compared to in...

August 22, 2024 | Thursday | News
Emergent BioSolutions Completes $30 Million Sale of Baltimore-Camden Facility to Bora Pharmaceuticals

Emergent BioSolutions Inc.  announced it has completed the sale of its drug product facility in Baltimore-Camden to an affiliate of B...

August 21, 2024 | Wednesday | News
GE HealthCare Partners with UC San Diego to Enhance MRI Techniques for Women's Pelvic Health

Project aims to increase access of advanced imaging techniques for clinicians to help drive improved diagnosis and management of female pelvic di...

August 20, 2024 | Tuesday | News
Emergent BioSolutions Collaborates with WHO and U.S. Government to Combat Mpox Outbreak in Central Africa

Active engagement with the World Health Organization, U.S. government and other global health leaders on critical efforts to prevent mpox disease ...

August 20, 2024 | Tuesday | News
Pfizer and BioNTech's Ambitious Combo Vaccine Shows Promise but Faces Hurdles in Phase 3 Trial

In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicit...

August 19, 2024 | Monday | News
Phanes Therapeutics Secures FDA Orphan Drug Designation for PT217 in Treating Neuroendocrine Carcinoma

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today th...

August 19, 2024 | Monday | News
Agilent Unveils Next-Generation J&W 5Q GC/MS Columns, Elevating Industry Standards in Chromatography

Agilent Technologies Inc.,  announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatogra...

August 16, 2024 | Friday | News
Thermo Fisher’s PPD Clinical Research Business Recognized as Industry Leader in Digital Services by ISG

The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, has been honored for industry leadership in digital ...

August 15, 2024 | Thursday | News
Gilead Sciences Announces FDA Accelerated Approval for Livdelzi® in Treating Primary Biliary Cholangitis

Gilead Sciences, Inc.  announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi® (seladelpar) fo...

August 15, 2024 | Thursday | News
Eli Lilly Opens 346,000 sq. ft. Seaport Innovation Center as New Hub for Genetic Medicine and East Coast Gateway Labs

Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway Labs ...

August 14, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close